Bank Of America Corp Zymeworks Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.43 $469,970 - $750,942	-101,069 Reduced 97.32%	2,786 $17,000
Q2 2022 Aug 12, 2022	BUY	$4.82 - $7.7 $477,888 - $763,431	99,147 Added 2105.93%	103,855 $550,000
Q1 2022 May 16, 2022	SELL	$6.0 - $16.98 $16 Million - $45.2 Million	-2,659,635 Reduced 99.82%	4,708 $31,000
Q4 2021 Feb 08, 2022	BUY	$15.19 - $29.33 $40.1 Million - $77.3 Million	2,636,728 Added 9548.17%	2,664,343 $43.7 Million
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $496,949 - $677,377	18,170 Added 192.38%	27,615 $802,000
Q2 2021 Sep 13, 2021	BUY	$26.5 - $38.23 $250,292 - $361,082	9,445 New	9,445 $328,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $949M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.